Intravenous and oral sulodexide versus coagulation activation markers in humans.
Borawski
Jacek
J
Dubowski
Miroslaw
M
Rydzewska-Rosolowska
Alicja
A
Mysliwiec
Michal
M
D000284:Administration, Oral; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects*; D006025:Glycosaminoglycans / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism*; D010865:Pilot Projects; D011446:Prospective Studies; D011516:Prothrombin / Q000378:metabolism*
D000925:Anticoagulants; D015415:Biomarkers; D006025:Glycosaminoglycans; D010446:Peptide Fragments; C045879:prothrombin fragment 1.2; C007858:glucuronyl glucosamine glycan sulfate; D011516:Prothrombin